Skye Bioscience
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
11250 El Camino Real Ste 100, San Diego,...Phone Number
(858) 410-0266Website
www.skyebioscience.comRevenue
-Stock Symbol
SKYEIndustry
About Skye Bioscience
Skye Bioscience, Inc. is a clinical-stage biotechnology company headquartered in San Diego, California, and publicly traded on Nasdaq under the ticker SKYE. The company develops next-generation therapies targeting G-protein-coupled receptors (GPCRs) for obesity, overweight, and related metabolic diseases. Its lead candidate, nimacimab, is a CB1 receptor antibody being evaluated in combination with GLP-1 therapies for weight loss in patients with obesity. Skye conducts research and development, manages clinical trials, and pursues strategic partnerships and licensing opportunities to advance its metabolic health pipeline.Explore more
SIC Code 87,873NAICS Code 54,541Ticker NASDAQ: SKYEShow moreSkye Bioscience Org Chart
Compare Similar Companies to Skye Bioscience
Compare insights from companies similar to Skye Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Skye Bioscience Tech Stack
A closer look at the technologies used by Skye Bioscience
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Skye Bioscience
Sign Up For FreeTo access detailed company insights
Skye Bioscience, Inc. is a clinical-stage biotechnology company headquartered in San Diego, California, and publicly traded on Nasdaq under the ticker SKYE. The company develops next-generation therapies targeting G-protein-coupled receptors (GPCRs) for obesity, overweight, and related metabolic diseases. Its lead candidate, nimacimab, is a CB1 rec... Read More